CDIP-2, a synthetic peptide derived from chemokine (C-C motif) ligand 13 (CCL13), ameliorates allergic airway inflammation

Clinical and Experimental Immunology

Volumn 152, Issue 2, 2008, Pages 354-363

  Mendez Enriquez, E ^a   Melendez, Y ^a   Martinez, F ^a   Baay, G ^a   Huerta Yepez, S ^a   Gonzalez Bonilla, C ^a   Fortoul, T I ^b   Soldevila, G ^a   Garcia Zepeda E A ^a,c  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

Author keywords

Allergy; Chemokine; Inflammation; Peptide

Indexed keywords

CDIP 2 PEPTIDE; CHEMOKINE; GAMMA CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 4; OVALBUMIN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHEMOTAXIS; DRUG ANTAGONISM; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY DISEASE; MALE; MONOCYTE; MOUSE; MUCUS SECRETION; NONHUMAN; PERITONITIS; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION;

ANIMALS; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG EVALUATION, PRECLINICAL; HUMANS; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MONOCYTE CHEMOATTRACTANT PROTEINS; MONOCYTES; OVALBUMIN; PEPTIDES; PERITONITIS; RESPIRATORY HYPERSENSITIVITY; TUMOR CELLS, CULTURED;

EID: 42049113651     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03619.x     Document Type: Article

References (27)

1. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000 12 : 121 7.
2. Van Coillie E, Van Damme J, Opdenakker G. The MCP/eotaxin subfamily of CC chemokines. Cytokine Growth Factor Rev 1999 10 : 61 86.
3. Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2001 2 : 108 15.
4. Fernandez EJ, Lolis E. Structure, function, and inhibition of chemokines. Annu Rev Pharmacol Toxicol 2002 42 : 469 99.
5. Monteclaro FS, Charo IF. The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation. J Biol Chem 1996 271 : 19084 92.
6. Tenscher K, Metzner B, Hofmann C, Schopf E, Norgauer J. The monocyte chemotactic protein-4 induces oxygen radical production, actin reorganization, and CD11b up-regulation via a pertussis toxin- sensitive G-protein in human eosinophils. Biochem Biophys Res Commun 1997 240 : 32 5.
7. Garcia-Zepeda EA, Combadiere C, Rothenberg ME et al. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J Immunol 1996 157 : 5613 26.
8. Taha RA, Minshall EM, Miotto D et al. Eotaxin and monocyte chemotactic protein-4 mRNA expression in small airways of asthmatic and nonasthmatic individuals. J Allergy Clin Immunol 1999 103 : 476 83.
9. Lamkhioued B, Garcia-Zepeda EA, Abi-Younes S et al. Monocyte chemoattractant protein (MCP)-4 expression in the airways of patients with asthma. Induction in epithelial cells and mononuclear cells by proinflammatory cytokines. Am J Respir Crit Care Med 2000 162 : 723 32.
10. Chakravorty SJ, Howie AJ, Girdlestone J, Gentle D, Savage CO. Potential role for monocyte chemotactic protein-4 (MCP-4) in monocyte/macrophage recruitment in acute renal inflammation. J Pathol 2001 194 : 239 46.
11. Jozsef L, Zouki C, Petasis NA, Serhan CN, Filep JG, Lipoxin A. 4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes. Proc Natl Acad Sci USA 2002 99 : 13266 71.
12. Iwamoto T, Okamoto H, Iikuni N et al. Monocyte chemoattractant protein-4 (MCP-4)/CCL13 is highly expressed in cartilage from patients with rheumatoid arthritis. Rheumatology (Oxf) 2006 45 : 421 4.
13. Yang D, Chen Q, Hoover DM et al. Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol 2003 74 : 448 55.
14. Martinez-Becerra F, Silva DA, Dominguez-Ramirez L et al. Analysis of the antimicrobial activities of a chemokine-derived peptide (CDAP-4) on Pseudomonas aeruginosa. Biochem Biophys Res Comms 2007 355 : 352 8.
15. McQuibban GA, Gong JH, Wong JP, Wallace JL, Clark-Lewis I, Overall CM. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 2002 100 : 1160 7.
16. Pertuz Belloso S, Ostoa Saloma P, Benitez I, Soldevila G, Olivos A, Garcia-Zepeda E. Entamoeba histolytica cysteine protease 2 (EhCP2) modulates leucocyte migration by proteolytic cleavage of chemokines. Parasite Immunol 2004 26 : 237 41.
17. Soldevila G, Licona I, Salgado A, Ramirez M, Chavez R, Garcia-Zepeda E. Impaired chemokine-induced migration during T-cell development in the absence of Jak 3. Immunology 2004 112 : 191 200.
18. Huerta-Yepez S, Hernandez-Pando R, Santos-Argumedo L et al. Therapeutic efficacy of an E. coli strain carrying an ovalbumin allergenic peptide as a fused protein to OMPC in a murine model of allergic airway inflammation. Vaccine 2003 21 : 566 78.
19. Proudfoot AE, Power CA, Rommel C, Wells TN. Strategies for chemokine antagonists as therapeutics. Semin Immunol 2003 15 : 57 65.
20. Clark-Lewis I, Kim KS, Rajarathnam K et al. Structure-activity relationships of chemokines. J Leukoc Biol 1995 57 : 703 11.
21. Garcia-Zepeda EA, Combadiere C, Rothenberg ME et al. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J Immunol 1996 157 : 5613 26.
22. Hemmerich S, Paavola C, Bloom A et al. Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2. Biochemistry 1999 38 : 13013 25.
23. Wells TN, Guye-Coulin F, Bacon KB. Peptides from the amino-terminus of RANTES cause chemotaxis of human T-lymphocytes. Biochem Biophys Res Commun 1995 211 : 100 5.
24. Loetscher P, Gong JH, Dewald B, Baggiolini M, Clark-Lewis I. N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities. J Biol Chem 1998 273 : 22279 83.
25. Crump MP, Gong JH, Loetscher P et al. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J 1997 16 : 6996 7007.
26. McQuibban GA, Gong JH, Tam EM, McCulloch CA, Clark-Lewis I, Overall CM. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 2000 289 : 1202 6.
27. De Lucca GV. Recent developments in CCR3 antagonists. Curr Opin Drug Discov Devel 2006 9 : 516 24.